+
+
.7★
Compounded liraglutide is a version of the medication made by a compounding pharmacy instead of a drug manufacturer. Compounding is the process of preparing custom medications, often used when a drug is in shortage or not available in a certain form. Liraglutide itself is a GLP-1 medication used for type 2 diabetes and obesity. It works like a natural hormone in your body to lower blood sugar, slow stomach emptying, reduce cravings, and increase fullness after eating.
Compounded Liraglutide works by mimicking the action of the GLP-1 hormone, which helps regulate blood sugar levels. It stimulates insulin secretion from your pancreas, reduces glucagon (a hormone that increases blood sugar), slows stomach emptying, and promotes a feeling of fullness.
Yes, liraglutide is a treatment for obesity and chronic weight management. Liraglutide is for adults with a BMI of 30 or higher or adults with a BMI of 27 or higher who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, sleep apnea, or high cholesterol.
Compounded Liraglutide is administered as a subcutaneous injection (under the skin) once daily. The injection can be self-administered or given by a healthcare professional. Your doctor will prescribe a slowly increasing dose to reduce your risk of side effects.
The most common side effects of Compounded Liraglutide include gastrointestinal symptoms, such as
These side effects are usually mild to moderate and tend to improve over time.
However, it’s important for you to be aware that more serious but rare side effects, such as pancreatitis, gallbladder disease, an increased risk of thyroid cancer, and allergic reactions, can occur. Your healthcare provider should monitor you for these side effects while on liraglutide.
Liraglutide, when used alone, has a low risk of causing hypoglycemia. However, if used in combination with other antidiabetic medications that can lower blood sugar, such as insulin or sulfonylureas, the risk of hypoglycemia may increase.
Liraglutide has been shown to improve blood sugar control within weeks of starting treatment. For weight management, gradual weight loss may be observed over several weeks or months.
Liraglutide is generally prescribed for adults with type 2 diabetes whose blood sugar is not adequately controlled with other antidiabetic medications. For weight management, it may be prescribed to individuals with a body mass index (BMI) above a certain threshold. However, individual circumstances should be discussed with a healthcare professional.
People who are pregnant or breastfeeding, have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or are allergic to liraglutide or any of its components should not take it.
Liraglutide can be used alone or in combination with other antidiabetic medications, such as metformin or insulin, depending on individual needs. Combining Liraglutide with other weight loss interventions should be discussed with a healthcare professional to assess potential interactions and optimize the overall approach.
How much weight you lose depends on many factors, including whether you can commit to a low-calorie diet and regular exercise.
Compounded Liraglutide is not a cure for diabetes or obesity. It is a medication that helps manage blood sugar levels in diabetes and aids in weight management. Diabetes management and weight loss involve a comprehensive approach, including lifestyle modifications and ongoing medical care.
Important Medication Info: FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or connected in any way to these companies or their products.
We do not supply these FDA-approved branded medications. Instead, we offer compounded versions when medically appropriate and legally permissible. These compounded medications are prepared by licensed pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved. This means they do not undergo FDA premarket review for safety, efficacy, or manufacturing quality. Compounded medications may play an important role for patients whose needs cannot be met by commercially available drugs, but they have not been demonstrated to the FDA to be safe or effective for any particular use.
Important Medication Info: FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or connected in any way to these companies or their products.
We do not supply these FDA-approved branded medications. Instead, we offer compounded versions when medically appropriate and legally permissible. These compounded medications are prepared by licensed pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved. This means they do not undergo FDA premarket review for safety, efficacy, or manufacturing quality. Compounded medications may play an important role for patients whose needs cannot be met by commercially available drugs, but they have not been demonstrated to the FDA to be safe or effective for any particular use.
Safety Info: Compounded liraglutide may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. Prescription medications available only if prescribed by the healthcare provider after an online consultation. This is a compounded medication.